Silberman David Insider Trades

Insider Trading History

Track insider trading activity for Silberman David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Compugen
Compugen CGEN
Chief Financial Officer
Holding Value $77.7k 35,500 shares
Last Trade
Mar 18, 2026 Sale
$193k 89,000 shares
$2.17
$2.19
Oramed Pharmaceuticals
Oramed Pharmaceuticals ORMP
Chief Financial Officer
Holding Value $1.34M 366,500 shares
Last Trade
Jan 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$326k 136,500 shares
$2.39
$3.65
Oramed Pharmaceuticals
Oramed Pharmaceuticals ORMP
Chief Financial Officer
Holding Value $840k 230,000 shares
Last Trade
May 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$97k 24,500 shares
$3.96
$3.65
Oramed Pharmaceuticals
Oramed Pharmaceuticals ORMP
Chief Financial Officer
Holding Value $750k 205,500 shares
Last Trade
Apr 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$222k 97,500 shares
$2.28
$3.65
Oramed Pharmaceuticals
Oramed Pharmaceuticals ORMP
Chief Financial Officer
Holding Value $394k 108,000 shares
Last Trade
Jul 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$330k 39,000 shares
$8.47
$3.65
Oramed Pharmaceuticals
Oramed Pharmaceuticals ORMP
Chief Financial Officer
Holding Value $252k 69,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$444k 32,000 shares
$13.89
$3.65
Oramed Pharmaceuticals
Oramed Pharmaceuticals ORMP
Chief Financial Officer
Holding Value $183k 50,000 shares
Last Trade
Sep 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.01M 50,000 shares
$20.19
$3.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up